GT
ZYME icon

Glenmede Trust’s Zymeworks ZYME Stock Holding History

Glenmede Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,395
Closed -$207K – 1271
2020
Q4 		$207K Buy
4,395
+405
+10% +$18.8K ﹤0.01% 1053
2020
Q3 		$185K Buy
3,990
+995
+33% +$34.2K ﹤0.01% 1040
2020
Q2 		$108K Buy
+2,995
New +$110K ﹤0.01% 1138

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Glenmede Trust's ZYME Position: Q1 2021 in Review

Glenmede Trust sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 4,395 shares — an estimated $207K sold.

Glenmede Trust first reported a position in ZYME in Q2 2020 and held it in 3 quarters. The position peaked at $207K in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Glenmede Trust reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Glenmede Trust sold 4,395 Zymeworks shares in Q1 2021, an estimated $207K.
  • Glenmede Trust first reported a position in Zymeworks in Q2 2020 and held it in 3 quarters.
  • Glenmede Trust's Zymeworks position peaked at $207K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.